Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QHSLab Inc. (USAQ : OTC)

• Company Description    QHSLab, Inc. is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to remotely monitor patients' vital signs and evaluate the effects of prescribed medicines and treatments on patients' health through real-time data transferred from patient to doctor. The company also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. The company changed its name to QHSLab from USA Equities Corp. in April 2022. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $0.15 Daily Weekly Monthly 20 Day Moving Average: 2,032 shares Shares Outstanding: 9.07 (millions) Market Capitalization: $1.36 (millions) Beta: -1.28 52 Week High: $0.40 52 Week Low: $0.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 36.36% 31.20% 12 Week 0.00% -7.17% Year To Date -8.54% -16.80%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 901 NORTHPOINT PARKWAY SUITE 302 - WEST PALM BEACH,FL 33407 USA ph: 929-379-6503 fax: - ir@usaqcorp.com http://www.usaqcorp.com

• General Corporate Information    Officers Troy Grogan - Chief Executive Officer; Chief Financial Officer a Troy Grogan - Chief Financial Officer - - - - - - - - - Peer Information QHSLab Inc. (CORR.) QHSLab Inc. (RSPI) QHSLab Inc. (CGXP) QHSLab Inc. (BGEN) QHSLab Inc. (GTBP) QHSLab Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90350R107 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 9.07 Most Recent Split Date: 5.00 (0.01:1) Beta: -1.28 Market Capitalization: $1.36 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.10 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -0.56% vs. Previous Quarter: 31.72% ROE 03/31/23 - - 12/31/22 - -275.57 09/30/22 - -191.35 ROA 03/31/23 - -0.22 12/31/22 - -47.86 09/30/22 - -48.94 Current Ratio 03/31/23 - 0.11 12/31/22 - 0.17 09/30/22 - 0.27 Quick Ratio 03/31/23 - 0.10 12/31/22 - 0.14 09/30/22 - 0.21 Operating Margin 03/31/23 - -80.44 12/31/22 - -80.13 09/30/22 - -80.41 Net Margin 03/31/23 - -80.44 12/31/22 - -80.13 09/30/22 - -80.41 Pre-Tax Margin 03/31/23 - -80.44 12/31/22 - -80.13 09/30/22 - -80.40 Book Value 03/31/23 - -12.21 12/31/22 - 0.01 09/30/22 - 0.03 Inventory Turnover 03/31/23 - 0.09 12/31/22 - 9.01 09/30/22 - 8.90 Debt-to-Equity 03/31/23 - - 12/31/22 - 2.30 09/30/22 - 0.73 Debt-to-Capital 03/31/23 - - 12/31/22 - 69.58 09/30/22 - 42.22

Powered by Zacks Investment Research ©